UV-Induced RPA1 Acetylation Promotes Nucleotide Excision Repair

Slides:



Advertisements
Similar presentations
Zilong Qiu, Anirvan Ghosh  Neuron 
Advertisements

Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 55, Issue 1, Pages (July 2014)
Volume 5, Issue 5, Pages (May 2004)
RhoGDI Is Required for Cdc42-Mediated Cellular Transformation
Volume 22, Issue 3, Pages (May 2006)
Phosphorylation of Cdc20 by Bub1 Provides a Catalytic Mechanism for APC/C Inhibition by the Spindle Checkpoint  Zhanyun Tang, Hongjun Shu, Dilhan Oncel,
Volume 57, Issue 3, Pages (February 2015)
Volume 54, Issue 1, Pages (April 2014)
Volume 19, Issue 1, Pages (April 2017)
Volume 36, Issue 2, Pages (October 2009)
Richard C. Centore, Stephanie A. Yazinski, Alice Tse, Lee Zou 
Volume 8, Issue 6, Pages (December 2001)
Volume 15, Issue 1, Pages (January 2012)
Volume 44, Issue 2, Pages (October 2011)
Eun-Joo Kim, Jeong-Hoon Kho, Moo-Rim Kang, Soo-Jong Um  Molecular Cell 
Wenqi Wang, Nan Li, Xu Li, My Kim Tran, Xin Han, Junjie Chen 
Volume 68, Issue 2, Pages e6 (October 2017)
TopBP1 Controls BLM Protein Level to Maintain Genome Stability
Volume 23, Issue 2, Pages (July 2006)
SUMO Promotes HDAC-Mediated Transcriptional Repression
Volume 15, Issue 4, Pages (April 2016)
Volume 43, Issue 2, Pages (July 2011)
Volume 34, Issue 3, Pages (August 2015)
Volume 18, Issue 5, Pages (January 2017)
The TRIM Family Protein KAP1 Inhibits HIV-1 Integration
Volume 11, Issue 2, Pages (February 2003)
Volume 118, Issue 1, Pages (July 2004)
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Volume 13, Issue 1, Pages (January 2008)
Volume 66, Issue 4, Pages e5 (May 2017)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 7, Issue 4, Pages (April 2001)
Shijiao Huang, Danming Tang, Yanzhuang Wang  Developmental Cell 
Per Stehmeier, Stefan Muller  Molecular Cell 
Volume 56, Issue 5, Pages (December 2014)
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Volume 90, Issue 4, Pages (August 1997)
Volume 115, Issue 2, Pages (October 2003)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Volume 20, Issue 9, Pages (August 2017)
Volume 18, Issue 12, Pages (March 2017)
TopBP1 Activates the ATR-ATRIP Complex
Volume 59, Issue 4, Pages (August 2015)
Volume 25, Issue 5, Pages (March 2007)
Volume 24, Issue 18, Pages (September 2014)
Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage  Dan Levy, Yaarit Adamovich,
Two Distinct Modes of ATR Activation Orchestrated by Rad17 and Nbs1
Volume 21, Issue 12, Pages (June 2011)
Volume 47, Issue 3, Pages (August 2012)
Shrestha Ghosh, Baohua Liu, Yi Wang, Quan Hao, Zhongjun Zhou 
SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function  Donghua Wen, Jianguo Wu, Lei Wang, Zheng.
Antonio Porro, Sascha Feuerhahn, Joachim Lingner  Cell Reports 
Volume 16, Issue 16, Pages (August 2006)
Transcriptional Regulation by p53 through Intrinsic DNA/Chromatin Binding and Site- Directed Cofactor Recruitment  Joaquin M Espinosa, Beverly M Emerson 
SIRT1 Regulates the Function of the Nijmegen Breakage Syndrome Protein
Volume 9, Issue 1, Pages (January 2002)
Volume 7, Issue 6, Pages (June 2001)
Volume 55, Issue 1, Pages (July 2014)
Volume 2, Issue 4, Pages (October 2012)
A Direct HDAC4-MAP Kinase Crosstalk Activates Muscle Atrophy Program
Volume 37, Issue 3, Pages (February 2010)
Volume 65, Issue 5, Pages e4 (March 2017)
Volume 41, Issue 4, Pages (February 2011)
Volume 13, Issue 1, Pages (October 2015)
Volume 10, Issue 2, Pages (February 1999)
Volume 31, Issue 5, Pages (September 2008)
Structural Basis of SOSS1 Complex Assembly and Recognition of ssDNA
Volume 50, Issue 5, Pages (June 2013)
Acetylation Regulates Transcription Factor Activity at Multiple Levels
Presentation transcript:

UV-Induced RPA1 Acetylation Promotes Nucleotide Excision Repair Hanqing He, Jiajia Wang, Ting Liu  Cell Reports  Volume 20, Issue 9, Pages 2010-2025 (August 2017) DOI: 10.1016/j.celrep.2017.08.016 Copyright © 2017 The Authors Terms and Conditions

Cell Reports 2017 20, 2010-2025DOI: (10.1016/j.celrep.2017.08.016) Copyright © 2017 The Authors Terms and Conditions

Figure 1 RPA1 Is Acetylated by GCN5 and PCAF (A) HEK293T cells were transiently transfected with plasmids encoding SFB-tagged RPA1 together with plasmids encoding Myc- or HA-tagged acetyltransferases. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (B) GCN5 acetylates RPA1 in a dose-dependent manner. HEK293T cells were transiently transfected with plasmids encoding SFB-tagged RPA1 together with increasing amounts of plasmid encoding Myc-tagged GCN5. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (C) The enzymatically inactive mutant of GCN5 fails to acetylate RPA1. HEK293T cells were transiently transfected with plasmids encoding SFB-tagged RPA1 together with plasmids encoding Myc-tagged wild-type GCN5 or its mutant YA/FA. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (D) Endogenously expressed RPA1 is acetylated in vivo. HeLa cells were either mock treated or treated with nicotinamide (10 mM) and TSA (10 μM) for 4 hr before they were collected. Cell lysates were then incubated with protein A agarose beads conjugated with RPA1 antibody, and western blot analysis was performed with indicated antibodies. (E) GCN5 acetylates RPA1 in vitro. His-tagged RPA1, GST-tagged GCN5-HAT, or GST alone were purified from E. coli. The purified proteins were incubated in reaction buffer in the presence or absence of the acetyl-CoA (2 mM) at 37°C for 1 hr. Upper panel: RPA1 acetylation was detected by immunoblotting. Lower panel: purified proteins visualized by Coomassie staining are shown. (F) HEK293T cells were transiently transfected with plasmids encoding SFB-tagged RPA1 together with plasmids encoding Myc-tagged GCN5 or PCAF. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (G) Association of endogenous RPA1 with GCN5 and PCAF. Cell lysates were incubated with protein A agarose beads conjugated with anti-RPA1 antibody, and western blot analysis was performed according to standard procedures. (H) Direct in vitro binding between recombinant His-RPA1 and GST-GCN5 or GST-PCAF purified from E. coli. GST serves as negative control for RPA1 binding. (Upper panel) RPA1 was detected by immunoblotting. (Lower panel) Purified proteins visualized by Coomassie staining are shown. Cell Reports 2017 20, 2010-2025DOI: (10.1016/j.celrep.2017.08.016) Copyright © 2017 The Authors Terms and Conditions

Figure 2 RPA1 Is Acetylated at Lysine 163 (A) Schematic representation of RPA1 mutants used in this study. (B) HEK293T cells were transiently transfected with indicated plasmids for 24 hr. Cell lysates were immunoprecipitated with anti-Myc antibody, and western blot analysis was performed with indicated antibodies. (C) GCN5 acetylates RPA1 at K163 in vivo. HEK293T cells were transiently transfected with the indicated plasmids for 24 hr. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (D) The K163R mutant interacts with GCN5 as efficiently as wild-type RPA1. HEK293T cells were transiently transfected with indicated plasmids for 24 hr. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (E) RPA1 is acetylated at K163. HEK293T cells transfected with the indicated plasmids were either mock treated or treated with nicotinamide (10 mM) and TSA (10 μM) for 4 hr before they were collected. Cell lysates were then incubated with protein A agarose beads conjugated with anti-Flag antibody, and western blot analysis was performed with indicated antibodies. (F) GCN5 acetylates RPA1 at K163 in vitro. Purified wild-type RPA1 or the K163R mutant were incubated with purified GCN5-HAT in reaction buffer in the presence or absence of the acetyl-CoA (2 mM) at 37°C for 1 hr. (Upper panel) RPA1 acetylation was detected by immunoblotting. (Lower panel) Purified proteins visualized by Coomassie staining are shown. (G) Sequence alignment of the region containing the acetylation site in RPA1 from different species. Cell Reports 2017 20, 2010-2025DOI: (10.1016/j.celrep.2017.08.016) Copyright © 2017 The Authors Terms and Conditions

Figure 3 HDAC6 and SIRT1 Mediate RPA1 Deacetylation (A and B) HDAC6 (A) and SIRT1 (B) mediate RPA1 deacetylation. HEK293T cells were transiently transfected with the indicated plasmids for 24 hr. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (C and D) The enzymatically inactive mutant of HDAC6 (2HA; C) or SIRT1 (HY; D) failed to deacetylate RPA1. HEK293T cells were transiently transfected with the indicated plasmids for 24 hr. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (E) HDAC6 deacetylates RPA1 in vitro. Bacterially purified RPA1 was in vitro acetylated by recombinant GCN5 HAT domain. Following this, acetylated RPA1, as a substrate, was incubated with recombinant HDAC6 at 37°C for 2 hr. The reaction mixtures were then subjected to SDS-PAGE and immunoblotted with anti-acetyl lysine antibody (upper panel). Purified proteins visualized by Coomassie staining are shown (lower panel). (F) SIRT1 deacetylates RPA1 in vitro. Bacterially purified RPA1 was in vitro acetylated by recombinant GCN5 HAT domain. Following this, acetylated RPA1, as a substrate, was incubated with recombinant SIRT1 in the presence of 5 mM NAD+ at 37°C for 2 hr. The reaction mixtures were then subjected to SDS-PAGE and immunoblotted with anti-acetyl lysine antibody (upper panel). Purified proteins visualized by Coomassie staining are shown (lower panel). (G) RPA1 interacts strongly with HDAC6. HEK293T cells were transiently transfected with plasmids encoding SFB-tagged RPA1 together with plasmids encoding Myc-tagged SIRT1 or HDAC6 for 24 hr. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (H) Direct in vitro binding between recombinant His-RPA1 and MBP-HDAC6 or MBP-SIRT1 purified from E. coli. MBP serves as negative control for RPA1 binding. (Upper panel) RPA1 was detected by immunoblotting. (Lower panel) Purified proteins visualized by Coomassie staining are shown. (I) Association of endogenous RPA1 with HDAC6. Cell lysates were incubated with protein A agarose beads conjugated with anti-RPA1 antibody, and western blot analysis was performed according to standard procedures. (J and K) Depletion of HDAC6 (J) or inhibition of HDAC6 activity (K) increases RPA1 acetylation. HeLa cells were infected with lentiviral shRNA constructs that target HDAC6 for 48 hr or were treated with HDAC6 inhibitor tubacin (20 μM) for 6 hr. Cell lysates were incubated with protein A agarose beads conjugated with anti-RPA1 antibody, and western blot analysis was performed with indicated antibodies. Cell Reports 2017 20, 2010-2025DOI: (10.1016/j.celrep.2017.08.016) Copyright © 2017 The Authors Terms and Conditions

Figure 4 UV Irradiation Stimulates RPA1 Acetylation (A) HeLa cells were treated with 1 μM CPT, 5 mM HU, or 40 J/m2 UV for 4 hr. Cell lysates were incubated with protein A agarose beads conjugated with anti-RPA1 antibody, and western blot analysis was performed with indicated antibodies. (B) HeLa cells were treated with the indicated doses of UV irradiation and harvested 4 hr later. Cell lysates were incubated with protein A agarose beads conjugated with anti-RPA1 antibody, and western blot analysis was performed with indicated antibodies. (C) HeLa cells were treated with 40 J/m2 UV and allowed to recover for the indicated times. Cell lysates were incubated with protein A agarose beads conjugated with anti-RPA1 antibody, and western blot analysis was performed with indicated antibodies. (D) UV irradiation triggers RPA1 acetylation at lysine 163. HeLa cells stably expressing HA-Flag tagged wild-type RPA1 or K163R mutant were treated with 40 J/m2 UV for 4 hr. Cell lysates were incubated with protein A agarose beads conjugated with anti-Flag antibody, and western blot analysis was performed with indicated antibodies. (E) GCN5 and PCAF are required for UV-induced RPA1 acetylation. HeLa cells infected with indicated lentiviral shRNAs were treated with 40 J/m2 UV for 4 hr. Cell lysates were incubated with protein A agarose beads conjugated with anti-RPA1 antibody, and western blot analysis was performed with indicated antibodies. (F) UV irradiation has no effect on the interaction between RPA1 and GCN5. HEK293T cells were transiently transfected with the indicated plasmids for 24 hr. Cells were then treated with 40 J/m2 UV and allowed to recover for 4 hr. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (G) UV irradiation disrupts the interaction between RPA1 and HDAC6. HEK293T cells were transiently transfected with the indicated plasmids for 24 hr. Cells were then treated with 40 J/m2 UV and allowed to recover for 4 hr. Cell lysates were immunoprecipitated with S beads, and western blot analysis was performed with indicated antibodies. (H and I) UV irradiation facilitates translocation of HDAC6 from the nucleus to the cytoplasm. HeLa cells transfected with Flag-tagged HDAC6 were either mock treated or treated with 40 J/m2 UV for 4 hr before fixing and processed for HDAC6 immunofluorescence (H). The nucleus/cytoplasm ratio of HDAC6 was quantified using NIH ImageJ software (I). (J) HeLa cells were treated with 40 J/m2 UV for 4 hr before they were collected. Cell lysates were separated into cytoplasmic and nuclear fractions. HDAC6 levels were analyzed by an anti-HDAC6 western blot. Anti-GAPDH and anti-PARP1/anti-MCM3 western blot analyses were also performed to detect the purity of cytoplasmic and nuclear fractions, respectively. Cell Reports 2017 20, 2010-2025DOI: (10.1016/j.celrep.2017.08.016) Copyright © 2017 The Authors Terms and Conditions

Figure 5 RPA1 Acetylation Is Required for Optimal Repair of UV-Induced DNA Damage (A) HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. The levels of the indicated proteins were analyzed by western blot. (B) RPA1 acetylation has no effect on assembly of the RPA complex. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. Cells were then either mock treated or treated with 40 J/m2 UV and allowed to recover for 4 hr. Cell lysates were incubated with protein A agarose beads conjugated with anti-Flag antibody, and western blot analysis was performed with indicated antibodies. (C) RPA1 acetylation is not required for its recruitment to sites of DNA damage. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. Cells were then either mock treated or treated with 40 J/m2 UV, 1 μM CPT, or 5 mM HU and allowed to recover for 1 hr. Cells were then fixed and processed for RPA1 immunofluorescence. (D) Mutation of the acetylation site of RPA1 renders the cell hypersensitive to UV irradiation. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. The resulting cells were treated with the indicated doses of UV, CPT, or HU. Cells were then permitted to grow for 14 days before staining. Experiments were performed in triplicates. Results shown are means of three independent experiments and were presented as means ± SEM. ∗∗p < 0.01; ∗∗∗p < 0.001. (E) RPA1 acetylation is not required for UV-induced PCNA monoubiquitylation. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. The resulting cells were either mock treated or treated with 40 J/m2 UV and allowed to recover for 4 hr. The levels of the indicated proteins were analyzed by western blot. (F and G) RPA1 acetylation is not required for Polη foci formation. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. The resulting cells were transfected with GFP- Polη and treated with 40 J/m2 UV. 4 hr later, cells were fixed and processed for Polη immunofluorescence. Representative Polη foci were shown (F). Quantification results were the average of three independent experiments and were presented as means ± SEM (G). More than one hundred cells were counted in each experiment. Cell Reports 2017 20, 2010-2025DOI: (10.1016/j.celrep.2017.08.016) Copyright © 2017 The Authors Terms and Conditions

Figure 6 RPA1 Acetylation Promotes NER (A–C) RPA1 acetylation is required for the efficient removal of UV-induced DNA lesions. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. The resulting cells were irradiated with UV through 5-μm filters and allowed to recover for the indicated times. Cells were then stained with antibody for CPD (A) or 6-4PP (B). Results shown are means of three independent experiments and were presented as means ± SEM (C). More than 500 CPD or 6-4PP spots were counted for each condition. (D) RPA1 acetylation enhances its interaction with XPA. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1, the K163R mutant, or the K163Q mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. Cells were then mock treated or treated with 40 J/m2 UV and allowed to recover for 4 hr. Cell lysates were incubated with protein A agarose beads conjugated with anti-Flag antibody, and western blot analysis was performed with indicated antibodies. (E) Inhibition of GCN5 decreases the interaction between RPA1 and XPA. HeLa cells were either mock treated or treated with GCN5 inhibitor MB-3 (50 μM). 11 hr later, cells were then treated with 40 J/m2 UV and allowed to recover for 4 hr. Cell lysates were incubated with protein A agarose beads conjugated with anti-RPA1 antibody, and western blot analysis was performed with indicated antibodies. (F) Inhibition of HDAC6 enhances the interaction between RPA1 and XPA. HeLa cells were either mock treated or treated with HDAC6 inhibitor tubacin (20 μM) for 6 hr. Cell lysates were incubated with protein A agarose beads conjugated with anti-RPA1 antibody, and western blot analysis was performed with indicated antibodies. (G and H) RPA1 acetylation is required for XPA retention at sites of UV damage. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. The resulting cells were irradiated with UV through 5-μm filters and allowed to recover for the indicated times. Cells were then stained with antibodies for XPA and RPA1 (α-HA; H). Quantification of the percentage of cells with RPA1-positive spots that are also positive for XPA is shown (G). Results shown are means of three independent experiments and were presented as means ± SEM. More than 200 RPA1-positive spots were counted for each condition. Cell Reports 2017 20, 2010-2025DOI: (10.1016/j.celrep.2017.08.016) Copyright © 2017 The Authors Terms and Conditions

Figure 7 RPA1 Acetylation Is Not Required for UV-Induced Damage Checkpoint Activation (A) RPA1 acetylation does not affect its ssDNA-binding ability. ssDNA-containing streptavidin beads were incubated with lysates prepared from RPA1-depleted HeLa cells stably expressing either wild-type RPA1 or the K163R mutant at 4°C for 1.5 hr. After washing, the samples were boiled with 2× SDS loading buffer, and western blot analysis was performed with indicated antibodies. (B) Mutation of the acetylation site of RPA1 does not affect its interaction with ATRIP. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. The resulting cells were treated with 40 J/m2 UV and allowed to recover for 4 hr. Cell lysates were immunoprecipitated with anti-Flag antibody, and western blot analysis was performed with indicated antibodies. (C) RPA1 acetylation is not required for ATRIP recruitment to UV-induced DNA damage sites. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. The resulting cells were irradiated with UV through 5-μm filters and allowed to recover for 4 hr. Cells were then stained with antibodies for ATRIP and Flag. (D) RPA1 acetylation is not required for UV-induced CHK1 phosphorylation. HeLa cells stably expressing HA-Flag-tagged wild-type RPA1 or the K163R mutant were infected with lentiviral shRNA constructs that target the 3′ UTR of RPA1 and cultured in medium containing puromycin for 2 days. The resulting cells were treated with 40 J/m2 UV and allowed to recover for the indicated times. Western blot analysis was performed with indicated antibodies. (E) A model of the role for RPA1 acetylation in the NER pathway. Cell Reports 2017 20, 2010-2025DOI: (10.1016/j.celrep.2017.08.016) Copyright © 2017 The Authors Terms and Conditions